Perspectives on Cutting-Edge Clinical Trials: A Conversation Between Michael Hofman, Johannes Czernin, and Jérémie Calais

Michael S. Hofman; Jérémie Calais; Johannes Czernin

doi:10.2967/jnumed.121.262681

Research ArticleDiscussions with Leaders

Perspectives on Cutting-Edge Clinical Trials

A Conversation Between Michael Hofman, Johannes Czernin, and Jérémie Calais

Michael S. Hofman, Jérémie Calais and Johannes Czernin

Journal of Nuclear Medicine August 2021, 62 (8) 1027-1030; DOI: https://doi.org/10.2967/jnumed.121.262681

Michael S. Hofman

1Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jérémie Calais

2Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johannes Czernin

2Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint
Michael Hofman, MBSS
Download figure
Open in new tab
Download powerpoint
FIGURE 1.
Infographic summarizing schema and results of ANZUP TheraP trial.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 62, Issue 8

August 1, 2021

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Perspectives on Cutting-Edge Clinical Trials

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Perspectives on Cutting-Edge Clinical Trials

Michael S. Hofman, Jérémie Calais, Johannes Czernin

Journal of Nuclear Medicine Aug 2021, 62 (8) 1027-1030; DOI: 10.2967/jnumed.121.262681

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Perspectives on Cutting-Edge Clinical Trials

Michael S. Hofman, Jérémie Calais, Johannes Czernin

Journal of Nuclear Medicine Aug 2021, 62 (8) 1027-1030; DOI: 10.2967/jnumed.121.262681

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
- REFERENCES
Figures & Data
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Main menu

User menu

Search

Perspectives on Cutting-Edge Clinical Trials

A Conversation Between Michael Hofman, Johannes Czernin, and Jérémie Calais

Article Figures & Data

Figures

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles